Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

As of March 2025, the FDA considers the semaglutide shortage resolved. The FDA has stated that, after a transition period to ensure continuity of supply, pharmacies must stop producing compounded ...

Unwanted weight gain occurs in 70% of women post-menopause. Menopause is associated with low ovarian but increased peripheral estrogens and a relative rise in androgen levels. 3 The result is ...

A health expert has detailed a lesser known side effect of Ozempic amid its continued use as a weight loss drug.

After adjusting for other factors, they found that the semaglutide users were overall 50% more likely to experience hair loss compared to the other group. Women were more likely to have this ...

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date.